Three‐Component Mixture Model‐Based Adverse Drug Event Signal Detection for the Adverse Event Reporting System. (9th August 2018)

• Record Type: Journal Article
• Authors: Zhang, Pengyue; Li, Meng; Chiang, Chien‐Wei; Wang, Lei; Xiang, Yang; Cheng, Lijun; Feng, Weixing; Schleyer, Titus K.; Quinney, Sara K.; Wu, Heng‐Yi; Zeng, Donglin; Li, Lang
• Is Part Of: CPT: pharmacometrics & systems pharmacology. Volume 7:Number 8(2018)
• Page Start: 499
• Page End: 506
• Publication Date: 2018-08-09
• Subjects: Pharmacokinetics -- Periodicals; Pharmacology -- Periodicals; Pharmacokinetics; Periodicals; 615.05
• DOI: 10.1002/psp4.12294
• Languages: English
• ISSNs: 2163-8306

Abstract

Abstract : The US Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) is an important source for detecting adverse drug event (ADE) signals. In this article, we propose a three‐component mixture model (3CMM) for FAERS signal detection. In 3CMM, a drug‐ADE pair is assumed to have either a zero relative risk (RR), or a background RR (mean RR = 1), or an increased RR (mean RR >1). By clearly defining the second component (mean RR = 1) as the null distribution, 3CMM estimates local false discovery rates (FDRs) for ADE signals under the empirical Bayes framework. Compared with existing approaches, the local FDR's top signals have noninferior or better sensitivities to detect true signals in both FAERS analysis and simulation studies. Additionally, we identify that the top signals of different approaches have different patterns, and they are complementary to each other.